March 2015: DNAlytics is granted an H2020 SME Instrument project (ADDITION) for a proposal addressing PHC12 in the context of RheumaKit.
30 January 2015: A new version of the LiblineaR R package is available (1.94-1). It now supports regression, on top of classification!
29 January 2015 – DNAlytics’ CEO featured in Trends-Tendance: “Pour une médecine anticipative” (“for an anticipatory medicine”), along with Bart De Moor (KUL), Tom Van Herpe (LOGIC-Insulin), Julien Sapin (Axinesis), Philippe Durieux (UCL – LTTO).
14 November 2014: The full RheumaKit solution has been CE marked. RheumaKit is thus commercially available in Europe.
07 October 2014 – DNAlytics featured in a book presenting a European survey of Biotech companies.
1 October 2014: DNAlytics welcomes Carole Bodart as Product Director.
September 2014: CEO of DNAlytics becomes laureate of the Reseau Entreprendre Belgique (REB).
27 May 2014: The sample collection and transportation kit of RheumaKit has been CE marked.
14 March 2014 – CEO of DNAlytics featured in the first issue of Polytech Louvain.
28 November 2013 – DNAlytics featured in Trends: Starter: DNAlytics.
1 October 2013: DNAlytics moves from UCL facilities to its new location in CEI2, still in Louvain-la-Neuve.
March 2013: A scientific abstract describing Rheumakit, an early diagnostic solution for patients with arthritis has been selected as winner of the “Inspiring young scientist” competition at Knowledge for Growth, organized by FlandersBio in Ghent on 30 May 2013.
28 April 2011 – DNAlytics wins two awards at the Mind&Market forum in Louvain-la-Neuve, Belgium. The first award is the “Best Health Project”, and the second is a nomination in the Belgian Microsoft Innovation Center workshop. Some comments and photos here.